211 related articles for article (PubMed ID: 30666721)
1. Seasonal influence on TORCH infection and analysis of multi-positive samples with indirect immunofluorescence assay.
Chen L; Liu J; Shi L; Song Y; Song Y; Gao Y; Dong Y; Li L; Shen M; Zhai Y; Cao Z
J Clin Lab Anal; 2019 May; 33(4):e22828. PubMed ID: 30666721
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of TORCH infections in women of childbearing age in Croatia.
Vilibic-Cavlek T; Ljubin-Sternak S; Ban M; Kolaric B; Sviben M; Mlinaric-Galinovic G
J Matern Fetal Neonatal Med; 2011 Feb; 24(2):280-3. PubMed ID: 20476874
[TBL] [Abstract][Full Text] [Related]
3. TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China.
Wang LC; Yan F; Ruan JX; Xiao Y; Yu Y
BMC Pregnancy Childbirth; 2019 Dec; 19(1):484. PubMed ID: 31818265
[TBL] [Abstract][Full Text] [Related]
4. [Correlation between TORCH infections and abnormal pregnant outcomes].
Zhang QQ; Cheng JZ; Wang FH
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Apr; 25(2):209-10. PubMed ID: 23894850
[TBL] [Abstract][Full Text] [Related]
5. Seroepidemiology of TORCH Infections among 1.7 Million Women of Childbearing Age in Rural China: A Population-Based Cross-Sectional Study.
Qin X; Zhang S; Liu H; Cheng G; Liu Y; Hu M; Liu N; Zhang M
Am J Trop Med Hyg; 2021 Sep; 105(5):1202-1209. PubMed ID: 34544045
[TBL] [Abstract][Full Text] [Related]
6. Association between false-positive TORCH and antiphospholipid antibodies in healthy pregnant women.
De Carolis S; Tabacco S; Rizzo F; Perrone G; Garufi C; Botta A; Salvi S; Benedetti Panici P; Lanzone A
Lupus; 2018 Apr; 27(5):841-846. PubMed ID: 29157179
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of toxoplasmosis, rubella, cytomegalovirus, and herpes (TORCH) infections among women attending the antenatal care clinic, maternity hospital in Abha, Southwestern Saudi Arabia.
Al-Hakami AM; Paul E; Al-Abed F; Alzoani AA; Shati AA; Assiri MI; Qasim AA; Riaz F; Moosa RA; Chandramoorthy HC
Saudi Med J; 2020 Jul; 41(7):757-762. PubMed ID: 32601646
[TBL] [Abstract][Full Text] [Related]
8. Seroepidemiology of TORCH antibodies in the reproductive-aged women in China.
Qi Y; Zhu S; Li C; Wu H; Yue H; Zhang Y; Zhu B; Ma J; Feng Z; Kong H; Cai X; Ruan Q
Eur J Obstet Gynecol Reprod Biol; 2020 Nov; 254():114-118. PubMed ID: 32957008
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of preconception TORCH infections and its influential factors: evidence from over 2 million women with fertility desire in southern China.
Han L; Li R; Xiong W; Hu Y; Wu J; Liu X; Nie H; Qin W; Ling L; Li M
BMC Womens Health; 2023 Aug; 23(1):425. PubMed ID: 37563634
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary study on ToRCH epidemic laws in Wuhan region].
Gong Z; Luo L; Xiao H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):139-41. PubMed ID: 12569781
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of torch infections and its associated poor outcome in high-risk pregnant women of Central India: Time to think for prevention strategies.
Manjunathachar HV; Singh KN; Chouksey V; Kumar R; Sharma RK; Barde PV
Indian J Med Microbiol; 2020; 38(3 & 4):379-384. PubMed ID: 33154250
[TBL] [Abstract][Full Text] [Related]
12. Is screening of TORCH worthwhile in women with bad obstetric history: an observation from eastern Nepal.
Kumari N; Morris N; Dutta R
J Health Popul Nutr; 2011 Feb; 29(1):77-80. PubMed ID: 21528793
[TBL] [Abstract][Full Text] [Related]
13. Screening cytomegalovirus, rubella and toxoplasma infections in pregnant women with unknown pre-pregnancy serological status.
Karacan M; Batukan M; Cebi Z; Berberoglugil M; Levent S; Kır M; Baksu A; Ozel E; Camlıbel T
Arch Gynecol Obstet; 2014 Dec; 290(6):1115-20. PubMed ID: 25027818
[TBL] [Abstract][Full Text] [Related]
14. [Investigation on TORCH infections for pregnant women and neonates in Yan'an City].
Zhang QQ; Cheng JZ
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Aug; 24(4):386, 392. PubMed ID: 23236780
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in western region of Turkey.
Tamer GS; Dundar D; Caliskan E
Clin Invest Med; 2009 Feb; 32(1):E43-7. PubMed ID: 19178878
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of toxoplasma gondii, rubella virus, cytomegalovirus herpes simplex virus (TORCH) and syphilis in Jamaican pregnant women.
Prabhakar P; Bailey A; Smikle MF; McCaw-Binns A; Ashley D
West Indian Med J; 1991 Dec; 40(4):166-9. PubMed ID: 1664562
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of
Halawi M; Al-Hazmi A; Aljuaid A; Allahyani M; Abdulaziz O; A Almalki A; Alqurni E; Althibity N; Kuriri H; Alosimi E; Alsiwiehri N; Almehmadi M
Pak J Biol Sci; 2021 Jan; 24(11):1169-1174. PubMed ID: 34842389
[TBL] [Abstract][Full Text] [Related]
18. Determining the IgM and IgG antibodies titer against HSV1, HSV2 and CMV in the serum of schizophrenia patients.
Mohagheghi M; Eftekharian MM; Taheri M; Alikhani MY
Hum Antibodies; 2018 Feb; 26(2):87-93. PubMed ID: 29036805
[TBL] [Abstract][Full Text] [Related]
19. Serological Screening of TORCH Pathogen Infections in Infertile Women of Childbearing Age in Northwest China.
Ren X; Wang K; Chang Z; Liu M; Cheng F; Min B; Wei S
Reprod Sci; 2024 Apr; ():. PubMed ID: 38630173
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of infectious agents in indigenous women of childbearing age in Venezuela].
Monsalve-Castillo FM; Costa-León LA; Castellano ME; Suárez A; Atencio RJ
Biomedica; 2012; 32(4):519-26. PubMed ID: 23715227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
